Premium
AbSci Corporation (ABSI)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | Dr. Zachariah JonassonChief Business Officer & CFO | -8,32k | 56,15k | Sale to Issuer | 6,75 | 241,93k | -3,32% |
| 2026-05-13 | Dr. Menelas Nicolas PangalosIndependent Director & Member of Scientific Advisory Board | 37,45k | 200,75k | Achat | 5,36 | 213,94k | 21,22% |
| 2026-04-10 | Redmile Group, LLCSociété | -645,87k | 1,92M | Vente | 2,98 | 1,34M | -32,52% |
| 2026-03-03 | Ms. Shelby WalkerChief Legal Officer | -9,83k | 27,51k | Sale to Issuer | 2,80 | 9,94k | -49,70% |
| 2026-03-03 | Dr. Zachariah JonassonChief Business Officer & CFO | -10,85k | 30,37k | Sale to Issuer | 2,80 | 229,41k | -4,52% |
| 2026-03-03 | Mr. Todd BedrickSenior VP & CAO | -5,28k | 14,79k | Sale to Issuer | 2,80 | 81,99k | -6,05% |
| 2026-03-03 | Mr. Sean McClainFounder, CEO, President & Director | -25,32k | 70,88k | Sale to Issuer | 2,80 | 8,83M | -0,29% |
| 2026-03-12 | Dr. Andreas BuschCo-Chair of Scientific Advisory Board | 100,00k | 229,00k | Achat | 2,29 | 319,60k | 45,54% |
| 2026-03-03 | Dr. Andreas BuschCo-Chair of Scientific Advisory Board | -1,26k | 3,52k | Sale to Issuer | 2,80 | 219,60k | -0,57% |
| 2026-03-02 | Dr. Zachariah JonassonChief Business Officer & CFO | -8,31k | 22,76k | Sale to Issuer | 2,74 | 213,09k | -3,75% |
| 2026-02-02 | Dr. Zachariah JonassonChief Business Officer & CFO | -17,50k | 52,31k | Sale to Issuer | 2,99 | 199,60k | -8,06% |
| 2026-02-02 | Mr. Sean McClainFounder, CEO, President & Director | -26,76k | 80,02k | Sale to Issuer | 2,99 | 8,80M | -0,30% |
| 2026-02-27 | Dr. Menelas Nicolas PangalosIndependent Director & Member of Scientific Advisory Board | 75,10k | 205,76k | Achat | 2,74 | 174,56k | 75,50% |
| 2026-02-23 | Mr. Sean McClainFounder, CEO, President & Director | 129,39k | 156,56k | Derivative Exercise and Retained Stock | 1,21 | 8,86M | 1,48% |
| 2026-02-23 | Mr. Sean McClainFounder, CEO, President & Director | -267,01k | 384,49k | Derivative Exercise and Sale | 1,21 - 2,65 | 8,86M | - |
| 2026-02-03 | Dr. Andreas BuschCo-Chair of Scientific Advisory Board | -1,47k | 4,39k | Sale to Issuer | 2,99 | 212,96k | -0,69% |
| 2026-02-02 | Mr. Todd BedrickSenior VP & CAO | -3,66k | 10,94k | Sale to Issuer | 2,99 | 77,37k | -4,52% |
| 2025-12-05 | Mr. François Adrianus van HoutenIndependent Director | 40,00k | 148,80k | Achat | 3,72 | 48,82k | 453,51% |
| 2025-11-30 | Dr. Zachariah JonassonChief Business Officer & CFO | -8,32k | 26,37k | Sale to Issuer | 3,17 | 180,06k | -4,42% |
| 2025-10-14 | Dr. Zachariah JonassonChief Business Officer & CFO | -387,00 | 1,42k | Sale to Issuer | 3,68 | 167,55k | -0,23% |
| 2025-10-14 | Mr. Sean McClainFounder, CEO, President & Director | -23,29k | 85,72k | Sale to Issuer | 3,68 | 8,76M | -0,27% |
| 2025-10-14 | Mr. Todd BedrickSenior VP & CAO | -21,95k | 80,78k | Sale to Issuer | 3,68 | 74,17k | -22,84% |
| 2025-10-14 | Dr. Andreas BuschCo-Chair of Scientific Advisory Board | -3,09k | 11,38k | Sale to Issuer | 3,68 | 186,72k | -1,63% |
| 2025-09-22 | Dr. Menelas Nicolas PangalosIndependent Director & Member of Scientific Advisory Board | 95,79k | 254,79k | Achat | 2,66 | 99,46k | 2 606,39% |
| 2025-09-22 | Mr. Todd BedrickSenior VP & CAO | 10,00k | 27,00k | Achat | 2,70 | 49,62k | 25,24% |
| 2025-08-31 | Dr. Zachariah JonassonChief Business Officer & CFO | -8,32k | 19,88k | Sale to Issuer | 2,39 | 166,97k | -4,75% |
| 2025-07-28 | Dr. Andreas BuschCo-Chair of Scientific Advisory Board | 50,00k | 152,00k | Achat | 3,04 | 131,48k | 61,36% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
